Michael McDermott - 22 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
Susan E. Grant, by power of atty., for Michael McDermott
Issuer symbol
PFE
Transactions as of
22 Feb 2023
Net transactions value
-$34,547
Form type
4
Filing time
24 Feb 2023, 19:52:26 UTC
Previous filing
01 Mar 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $401,472 +13,307 +18% $30.17 88,957 22 Feb 2023 Direct F1
transaction PFE Common Stock Tax liability $82,005 -1,935 -2.2% $42.38 87,022 22 Feb 2023 Direct F2
transaction PFE Common Stock Tax liability $354,014 -8,101 -9.3% $43.70 78,921 22 Feb 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -13,307 -100% $0.000000* 0 22 Feb 2023 Common Stock 13,307 $30.17 Direct F5
transaction PFE Stock Appreciation Rights Award $0 +45,920 $0.000000 45,920 23 Feb 2023 Common Stock 45,920 $42.30 Direct F5
transaction PFE Stock Appreciation Rights Award $0 +39,965 $0.000000 39,965 23 Feb 2023 Common Stock 39,965 $42.30 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F6 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.